Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 2022 Jul 7;109(7):1344. doi: 10.1016/j.ajhg.2022.06.003

Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study

Lisanne van Prooyen Schuurman, Erik A Sistermans, Diane Van Opstal, Lidewij Henneman, Mireille N Bekker, Caroline J Bax, Mijntje J Pieters, Katelijne Bouman, Sonja de Munnik, Nicolette S den Hollander, Karin EM Diderich, Brigitte HW Faas, Ilse Feenstra, Attie TJI Go, Mariëtte JV Hoffer, Marieke Joosten, Fenne L Komdeur, Klaske D Lichtenbelt, Maria P Lombardi, Marike G Polak, Fernanda S Jehee, Heleen Schuring-Blom, Servi JC Stevens, Malgorzata I Srebniak, Ron F Suijkerbuijk, Gita M Tan-Sindhunata, Karuna RM van der Meij, Merel C van Maarle, Vivian Vernimmen, Shama L van Zelderen-Bhola, Nicolien T van Ravesteyn, Maarten FCM Knapen, Merryn VE Macville, Robert-Jan H Galjaard ∗; The Dutch NIPT consortium
PMCID: PMC9300874  PMID: 35803237

Main Text

(The American Journal of Human Genetics 109, 1140–1152; June 2, 2022)

In the originally published version of this article, in Table 3, the column heading “Placenta biopsies” was placed erroneously under “Available clinical follow-up” instead of under “Available cytogenic follow-up.” The authors apologize for this error, which has been corrected online.

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES